Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy

HIV Clinical Trials

Volumn 12, Issue 6, 2011, Pages 333-338

  Garvey, Lucy ^a,b   Surendrakumar, Veena ^a   Winston, Alan ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

combination antiretroviral therapy; HIV; neurocognitive impairment

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COGNITIVE DEFECT; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANTI-HIV AGENTS; COGNITION DISORDERS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84255188718     PISSN: 15284336     EISSN: 19455771     Source Type: Journal    
DOI: 10.1310/hct1206-333     Document Type: Article

References (19)

1. Dore GJ, et al. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 1999;13(10):1249-1253. (Pubitemid 29361096)
2. Becker JT, et al. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS. 2004;18(Suppl 1):S11-18. (Pubitemid 38365901)
3. Joska JA, et al. Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav. 2011;15(6): 1197-1203.
4. Ryan EL, et al. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology. 2004;62(6):957-962. (Pubitemid 38435785)
5. Thiyagarajan A, et al. Cerebral function tests reveal differences in HIV-infected subjects with and without chronic HCV co-infection. Clin Microbiol Infect. 2010;16(10): 1579-1584.
6. Letendre S, et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65(1):65-70.
7. Heaton RK, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10(3):317-331. (Pubitemid 38779804)
8. Sacktor N, et al. HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001;56(2):257-260. (Pubitemid 32095372)
9. Bhaskaran K, et al. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol. 2008;63(2):213-221. (Pubitemid 351355300)
10. Wright E, et al. Neurologic disorders are prevalent in HIVpositive outpatients in the Asia-Pacific region. Neurology. 2008;71(1):50-56.
11. Heaton RK, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75(23):2087-2096.
12. Cysique LA, Brew BJ. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol. 2011;17(2):176-183.
13. Letendre S, et al. Correlates of CSF viral loads in 1221 volunteers in the CHARTER Cohort. Presented at: Seventeenth Conference on Retroviruses and Opportunistic Infections; 2010; San Francisco, CA.
14. Cysique LA, et al. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol. 2006;21(2):185-194. (Pubitemid 43117194)
15. Winston A, et al. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. Clin Infect Dis. 2010;50(6):920-929.
16. Sacktor NC, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19(13):1367-1374. (Pubitemid 41800672)
17. Antinori A, et al. Updated research nosology for HIVassociated neurocognitive disorders. Neurology. 2007;69(18):1789-1799. (Pubitemid 350059308)
18. Stanton DL, et al. Functional status of persons with HIV infection in an ambulatory setting. J Acquir Immune Defic Syndr. 1994;7(10):1050-1056.
19. Gonzalez R, et al. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc. 2003;9(1):64-71. (Pubitemid 36150139)